β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature

β-Blockers (BBs) are an essential class of cardiovascular medications for reducing morbidity and mortality in patients with heart failure (HF). However, a large body of data indicates that BBs should not be used as first-line therapy for hypertension (HTN). Additionally, new data have questioned the...

Descripción completa

Detalles Bibliográficos
Autores principales: DiNicolantonio, James J, Fares, Hassan, Niazi, Asfandyar K, Chatterjee, Saurav, D'Ascenzo, Fabrizio, Cerrato, Enrico, Biondi-Zoccai, Giuseppe, Lavie, Carl J, Bell, David S, O'Keefe, James H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Cardiac Risk Factors and Prevention
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371808/
https://www.ncbi.nlm.nih.gov/pubmed/25821584
http://dx.doi.org/10.1136/openhrt-2014-000230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371808/
https://www.ncbi.nlm.nih.gov/pubmed/25821584
http://dx.doi.org/10.1136/openhrt-2014-000230

Ejemplares similares